Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 230 results.

Thumbnail for Can Menin Inhibitors Bridge Patients to Transplant? Response Depth, MRD Negativity, and Differentiation Syndrome in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia

AML - 954

Can Menin Inhibitors Bridge Patients to Transplant? Response Depth, MRD Negativity, and Differentiation Syndrome in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia

Fnu Ashvin Rajeev Pillai

Poster Presenter: Fnu Ashvin Rajeev Pillai

Thumbnail for CDK4/6 Inhibitor Use and Risk of Therapy-Related Myeloid Neoplasms Following Chemotherapy for HR+/HER2- Breast Cancer: A Landmark Competing Risks Analysis

AML - 961

CDK4/6 Inhibitor Use and Risk of Therapy-Related Myeloid Neoplasms Following Chemotherapy for HR+/HER2- Breast Cancer: A Landmark Competing Risks Analysis

Jacqueline T Nguyen

Poster Presenter: Jacqueline T Nguyen

Thumbnail for MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

AML - 971

MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis

Sai Mourya Meda

Poster Presenter: Sai Mourya Meda

Thumbnail for Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

AML - 993

Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

Shyam Srinivasan

Poster Presenter: Shyam Srinivasan

Thumbnail for Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

AML - 998

Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

Milvyd? Tamutyt?-Jankausk?

Poster Presenter: Milvyd? Tamutyt?-Jankausk?

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.